Your browser doesn't support javascript.
loading
Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0ΔNLS vaccine against ocular HSV-1 challenge.
Carr, Daniel J J; Berube, Amanda N; Filiberti, Adrian; Gmyrek, Grzegorz B.
Affiliation
  • Carr DJJ; Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Electronic address: dan-carr@ouhsc.edu.
  • Berube AN; Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
  • Filiberti A; Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
  • Gmyrek GB; Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Vaccine ; 39(18): 2526-2536, 2021 04 28.
Article in En | MEDLINE | ID: mdl-33814229

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Fc / Herpes Simplex Virus Vaccines / Eye Diseases / Herpes Simplex Limits: Animals Language: En Journal: Vaccine Year: 2021 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Fc / Herpes Simplex Virus Vaccines / Eye Diseases / Herpes Simplex Limits: Animals Language: En Journal: Vaccine Year: 2021 Document type: Article Country of publication: Netherlands